Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Argatroban Market 2016 Share, Trend, Segmentation and Forecast to 2021

Monday, October 17, 2016 22:38
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Request a sample report @ https://www.wiseguyreports.com/sample-request/689041-global-argatroban-market-by-forecast-to-2021

Scope of the Report: 
This report focuses on the Argatroban in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers 
Pfizer 
SANDOZ 
GlaxoSmithKline 
fresenius-kabi 
Eagle Pharmaceuticals 
Mitsubishi Tanabe Pharma 
Teva Pharmaceutical Industries 
WEST-WARD

Market Segment by Regions, regional analysis covers 
North America (USA, Canada and Mexico) 
Europe (Germany, France, UK, Russia and Italy) 
Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
Latin America, Middle East and Africa

Market Segment by Type, covers 
Argatroban Powder 
Argatroban Injection

Market Segment by Applications, can be divided into 
Heparin-induced thrombocytopenia (HIT) 
Percutaneous Coronary Intervention 
Cerebral arterial thrombosis

There are 13 Chapters to deeply display the global Argatroban market.

Chapter 1, to describe Argatroban Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Argatroban, with sales, revenue, and price of Argatroban, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Argatroban, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Argatroban sales channel, distributors, traders, dealers, appendix and data source.

 

 

 

Complete report details @ https://www.wiseguyreports.com/reports/689041-global-argatroban-market-by-forecast-to-2021                      

Key points in table of content

1 Market Overview 
1.1 Argatroban Introduction 
1.2 Market Analysis by Type 
1.2.1 Argatroban Powder 
1.2.2 Argatroban Injection 
1.2.3 
1.3 Market Analysis by Applications 
1.3.1 Heparin-induced thrombocytopenia (HIT) 
1.3.2 Percutaneous Coronary Intervention 
1.3.3 Cerebral arterial thrombosis 
1.4 Market Analysis by Regions 
1.4.1 North America (USA, Canada and Mexico) 
1.4.1.1 USA 
1.4.1.2 Canada 
1.4.1.3 Mexico 
1.4.2 Europe (Germany, France, UK, Russia and Italy) 
1.4.2.1 Germany 
1.4.2.2 France 
1.4.2.3 UK 
1.4.2.4 Russia 
1.4.2.5 Italy 
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
1.4.3.1 China 
1.4.3.2 Japan 
1.4.3.3 Korea 
1.4.3.4 India 
1.4.3.5 Southeast Asia 
1.4.4 Latin America, Middle East and Africa 
1.4.4.1 Brazil 
1.4.4.2 Egypt 
1.4.4.3 Saudi Arabia 
1.4.4.4 South Africa 
1.4.4.5 Nigeria 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force 
2 Manufacturers Profiles 
2.1 Pfizer 
2.1.1 Business Overview 
2.1.2 Argatroban Type and Applications 
2.1.2.1 Type 1 
2.1.2.2 Type 2 
2.1.3 Pfizer Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.2 SANDOZ 
2.2.1 Business Overview 
2.2.2 Argatroban Type and Applications 
2.2.2.1 Type 1 
2.2.2.2 Type 2 
2.2.3 SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.3 GlaxoSmithKline 
2.3.1 Business Overview 
2.3.2 Argatroban Type and Applications 
2.3.2.1 Type 1 
2.3.2.2 Type 2 
2.3.3 GlaxoSmithKline Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.4 fresenius-kabi 
2.4.1 Business Overview 
2.4.2 Argatroban Type and Applications 
2.4.2.1 Type 1 
2.4.2.2 Type 2 
2.4.3 fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.5 Eagle Pharmaceuticals 
2.5.1 Business Overview 
2.5.2 Argatroban Type and Applications 
2.5.2.1 Type 1 
2.5.2.2 Type 2 
2.5.3 Eagle Pharmaceuticals Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.6 Mitsubishi Tanabe Pharma 
2.6.1 Business Overview 
2.6.2 Argatroban Type and Applications 
2.6.2.1 Type 1 
2.6.2.2 Type 2 
2.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.7 Teva Pharmaceutical Industries 
2.7.1 Business Overview 
2.7.2 Argatroban Type and Applications 
2.7.2.1 Type 1 
2.7.2.2 Type 2 
2.7.3 Teva Pharmaceutical Industries Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
2.8 WEST-WARD 
2.8.1 Business Overview 
2.8.2 Argatroban Type and Applications 
2.8.2.1 Type 1 
2.8.2.2 Type 2 
2.8.3 WEST-WARD Argatroban Sales, Price, Revenue, Gross Margin and Market Share 
3 Global Argatroban Market Competition, by Manufacturer 
3.1 Global Argatroban Sales and Market Share by Manufacturer 
3.2 Global Argatroban Revenue and Market Share by Manufacturer 
3.3 Market Concentration Rate 
3.3.1 Top 3 Argatroban Manufacturer Market Share 
3.3.2 Top 6 Argatroban Manufacturer Market Share 
3.4 Market Competition Trend 

Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=689041

 

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)           

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.